ValuEngine lowered shares of Reliv (NASDAQ:RELV) from a buy rating to a hold rating in a report published on Wednesday morning.
Shares of RELV stock opened at $4.81 on Wednesday. Reliv has a fifty-two week low of $3.72 and a fifty-two week high of $13.77.
TRADEMARK VIOLATION WARNING: This piece was originally posted by Ticker Report and is owned by of Ticker Report. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.tickerreport.com/banking-finance/3338216/reliv-relv-downgraded-by-valuengine.html.
Reliv' International, Inc develops, manufactures, and markets nutritional supplements that address basic nutrition, wellness needs, weight management, and sports nutrition. It offers 20 nutritional supplements, primarily, including Reliv Classic and Reliv NOW, which are basic nutritional supplements containing a balanced blend of vitamins, minerals, proteins, and herbs; Innergize!, an isotonic sports supplement in two flavors; FibRestore, a fiber and antioxidant supplement; and LunaRich X, a soy concentrate with elevated levels of lunasin in capsule form.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Reliv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reliv and related companies with MarketBeat.com's FREE daily email newsletter.